Tylenol, Listerine and Band-Aid maker Kenvue is the latest in the health-related sector to attract an activist investor. And not just any corporate agitator, Starboard Value, which in recent days ...
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...